Month: August 2020

PHILADELPHIA and BOSTON and ATHENS, Greece, Aug. 10, 2020 (GLOBE NEWSWIRE) — Hill International (NYSE:HIL) (Hill), the global leader in managing construction risk, announced today that Engineering News-Record (ENR) magazine has recognized the Four Seasons Astir Palace Hotel Athens, Northeastern University’s Interdisciplinary Science and Engineering Complex (ISEC) Pedestrian Crossing, and Boeing’s V-22 Osprey Future Factory with Awards of Merit.The Four Seasons Astir Palace Hotel AthensENR Global Best Projects Award of Merit, Residential/HospitalityThe Four Seasons Astir Palace Hotel Athens is an iconic hotel near Athens, Greece. Since the 1960s, the Hotel has been the crown jewel of the Athenian Riviera and a landmark for Greece’s tourism sector. The owner’s vision for the project respected Astir’s established history and identity...

Strong Momentum in Dosing Patients and Manufacturing Clinical Supply for RTX-240 Phase 1/2 Solid Tumor Clinical TrialInvestigational New Drug Application on Track by Year-End for RTX-321 for HPV-Positive CancersCAMBRIDGE, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines, today reported second quarter 2020 financial results and provided an overview of operational progress.“Rubius Therapeutics is making excellent progress in advancing our pipeline of Red Cell Therapeutics™, including the completion of dosing of the second cohort in the RTX-240 Phase 1/2 solid tumor clinical trial with no observed adverse events to date attributed to RTX-240. As we enter the...

TORONTO, Aug. 10, 2020 (GLOBE NEWSWIRE) — Osisko Mining Inc. (OSK:TSX. “Osisko” or the “Corporation”) is pleased to provide new analytical results from the ongoing definition and expansion drill program at its 100% owned Windfall gold project located in the Abitibi greenstone belt, Urban Township, Eeyou Istchee James Bay, Québec.Drill hole OSK-W-20-2059-W4 returned an outstanding intercept averaging 202 g/t Au over 28 metres core length in Lynx 4 (202 g/t Au over 9.0 metres estimated true width). This drill hole intercepted the mineralized zone at a lower than usual core angle (20 degrees), resulting in an estimated true width of approximately 30% of the core length. The interval expands the Lynx 348 Wireframe by 25 metres to the southwest.Osisko President and Chief Executive Officer John Burzynski commented:...

AUSTIN, Texas, Aug. 10, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced financial and business results for its Second Quarter Fiscal Year 2020 ended June 30, 2020.Q2 2020 net loss was $1.8 million, or $0.45 per share, including payments to NanoTx LLC of $0.78 million. Net cash used in operating activities for the six months ended June 30, 2020 was approximately $2.9 million. Plus Therapeutics ended Q2 2020 with approximately $9.3 million of cash and cash equivalents.The Plus Therapeutics portfolio has three clinical-stage injectable drugs being developed on a unique nanotechnology platform designed to provide patient benefits through improved formulation and delivery innovation. The Company believes the platform can enable significant potential enhancements of safety, efficacy and...

With respect to the announcement of the notice of the Extraordinary General Meeting on 9 August, 2020, the Board of Directors of Aino Health AB (publ) (the “Company”) wishes to highlight that large owners of the Company propose that the Extraordinary General Meeting resolves on a directed issue of a maximum of 1,529,758 warrants to members of the management team in Aino Health.The right to subscribe for new warrants shall, with deviation from the shareholders’ preferential rights, be given to;Jyrki Eklund, CEO, with a maximum of 1,189,812 warrantsHirvensalmen Satama Koy (controlled by Jochen Saxelin, CFO) with a maximum of 339,946 warrants.Each warrant shall give the right to subscribe for one new share in the Company at a subscription price of SEK 3.50 per share. Subscription of shares based on the warrants shall take place in...

Med anledning av offentliggörandet av kallelsen till extra bolagsstämman den 9 augusti 2020, vill styrelsen för Aino Health AB (publ) (”Bolaget”) belysa att huvudägare i Bolaget föreslår att bolagsstämman fattar beslut om en riktad emission av högst 1 529 758 teckningsoptioner till ledande befattningshavare i Aino Health.Rätt att teckna nya teckningsoptioner ska, med avvikelse från aktieägarnas företrädesrätt, tillkomma;Jyrki Eklund, VD, om högst 1 189 812 optionerHirvensalmen Satama Koy (kontrollerat av Jochen Saxelin, CFO) om högst 339 946 optioner.Varje teckningsoption ska medföra en rätt att teckna en ny aktie i Bolaget till en teckningskurs om 3,50 kronor per aktie. Teckning av aktier med stöd av teckningsoptionerna ska ske i enlighet med villkoren för teckningsoptionerna under tiden från och med den 1 januari 2023 till och med den...

SAMPO PLC                        MANAGERS’ TRANSACTIONS                    10 August 2020 at 2:40 pmSampo plc: Managers’ Transactions (Lapveteläinen)Sampo plc (business code 0142213-3) has received the following notification under Article 19 of the Market Abuse Regulation.____________________________________________Person subject to the notification requirementName: Leviathan OyPosition: Closely associated person(X) Legal person(1):Person Discharging Managerial Responsibilities In IssuerName: Patrick LapveteläinenPosition: Other senior managerIssuer: Sampo plcLEI: 743700UF3RL386WIDA22Notification type: INITIAL NOTIFICATIONReference number: 743700UF3RL386WIDA22_20200810135144_2____________________________________________Transaction date: 2020-08-06Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009003305Nature of the transaction:...

SAMPO OYJ                                              JOHDON LIIKETOIMET         10.8.2020 klo 14.40Sampo Oyj: Johdon liiketoimet (Lapveteläinen)Sampo Oyj (Y-tunnus 0142213-3) on vastaanottanut seuraavan markkinoiden väärinkäyttöasetuksen 19. artiklan mukaisen ilmoituksen.____________________________________________IlmoitusvelvollinenNimi: Leviathan OyAsema: Lähipiiriin kuuluva henkilö(X) Oikeushenkilö(1):Liikkeeseenlaskijassa johtotehtävissä toimiva henkilöNimi: Patrick LapveteläinenAsema: Muu ylin johtoLiikkeeseenlaskija: Sampo OyjLEI: 743700UF3RL386WIDA22Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 743700UF3RL386WIDA22_20200810135144_2____________________________________________Liiketoimen päivämäärä: 2020-08-06Kauppapaikka: NASDAQ HELSINKI LTD (XHEL)Instrumenttityyppi: OSAKEISIN: FI0009003305Liiketoimen luonne: HANKINTALiiketoimien...